anti-BFRF3 antibody product blog
Tags: Antibody; Polyclonal Antibody; BFRF3; Epstein-Barr virus Capsid protein VP26; anti-BFRF3 antibody;
The BFRF3 bfrf3 (Catalog #MBS1497664) is an Antibody produced from Rabbit and is intended for research purposes only. The product is available for immediate purchase. The Rabbit anti-Epstein-Barr virus Capsid protein VP26 polyclonal Antibody reacts with Epstein-Barr virus and may cross-react with other species as described in the data sheet. MyBioSource\'s Epstein-Barr virus Capsid protein VP26 can be used in a range of immunoassay formats including, but not limited to, ELISA (EIA). Researchers should empirically determine the suitability of the BFRF3 bfrf3 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.The BFRF3 bfrf3 product has the following accession number(s) (GI #82503209) (NCBI Accession #YP_401651.1) (Uniprot Accession #P14348). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Storage Buffer: Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, PH 7.4
Conjugate: Non-conjugated. Immunogen: Recombinant Epstein-Barr virus Capsid protein VP26 protein(31-176AA)
Species: Epstein-Barr virus
Research Area: Others
Target Names: SCP. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing BFRF3 are readily searchable from our website. Different antibodies against the same target such as BFRF3 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.